Skip to product information
1 of 1

Boehringer Ingelheim

UlcerGard

UlcerGard

Regular price $41.39 USD
Regular price Sale price $41.39 USD
Sale Sold out
Shipping calculated at checkout.
NOTIFY ME WHEN IN STOCK
Size
Some horses are more prone to stress than others, but for many, even small changes in routine can potentially lead to gastric ulcers. Stomach ulcers in horses are more common than once believed. Studies have demonstrated stomach ulcers in over 90% of racehorses and around 60% of performance horses in various disciplines*. Before stress has a chance to cause gastric ulcers, use UlcerGard. Deliver targeted, effective medication during anticipated stressful times, such as traveling, competition, stall confinement and strenuous exercise. This allows for proven prevention of gastric ulcers in otherwise healthy horses who are at risk due to increased stress. UlcerGard is the only ulcer medication for horses proven to be safe and effective and approved by the FDA to prevent equine ulcers. Specially formulated to survive the acidic stomach environment allowing proper absorption. Blocks acid production at the proton pump regardless of stimuli.

1 Count provides 4 doses; 6 Pack provides 24 total doses.
6 pack is perfect for on-the-go or at the show; provides enough protection for multiple horses. Easy to pack and easy to carry.

Contains 2.28 gm omeprazole per tube.

Directions: For 600-1,200 lb horse, give 0.45 mg/lb (1/4 syringe) on back of tongue or deep in cheek pouch; Over 1,200 lbs, give 0.9 mg/lb (1/2 syringe). For horses under 600 lbs, consult a veterinarian. May be safely used in breeding stallions; safety in pregnant mares has not been determined.

Manufacturer and/or Label Information

BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
3239 SATELLITE BLVD., BLDG 500, DULUTH, GA, 30096
Telephone: 800-325-9167
Customer Service: 800-243-0127
Fax: 816-236-2717
Website: www.boehringer-ingelheim.com
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.
Ulcergard®

Boehringer Ingelheim Animal Health

(omeprazole)

Oral Paste for Horses

Approved by FDA under NADA # 141-227

PREVENTS STOMACH ULCERS BY REDUCING ACID PRODUCTION

Stomach ulcers are more common in horses than once believed. Studies have demonstrated stomach ulcers in over 90% of racehorses and 60% of performance horses in various disciplines. Horses secrete acid in their stomach 24 hours a day. Horses on grass pasture or eating large quantities of roughage infrequently develop stomach ulcers. Horses without continual access to roughage or in rigorous training are at greater risk of stomach ulceration due to the effects of acid on the stomach lining. The additional stresses of traveling, competition, stall confinement, and strenuous exercise can also contribute to the development of stomach ulcers in horses. ULCERGARD works to prevent stomach ulcers in horses. The active ingredient in ULCERGARD, omeprazole has been extensively tested for safety and effectiveness. It works by reducing the production of acid in the horse’s stomach. To help horses maintain optimal gastric health, it is recommended that ULCERGARD be administered during stressful events or activities that may induce stomach ulcers. Such conditions may include: training, racing, showing, traveling, stall confinement, and competition.

DIRECTIONS FOR USE: Each syringe contains 4 individual daily doses for horses weighing 600-1200 lbs. Please refer to the following dosage chart for help in determining the correct dose for your horse.

ULCERGARD® DOSAGE CHART

HORSE WEIGHT

DOSE*

Less than 600 lbs.

Consult a veterinarian

600-1200 lbs.

1 dose per day

over 1200 lbs.

2 doses once per day

*Duration of 8 or 28 days

SYRINGE INSTRUCTIONS:

1) To set the syringe plunger, while holding plunger, turn the knurled ring on the plunger 1/4 turn to the left and slide the knurled ring along the plunger shaft so that the side nearest the barrel is at the appropriate daily dose marking, aligning the arrow on the plunger with the notch on the ring, as shown in the pictogram.

2) Lock the ring in place by making 1/4 turn to the right. Ensure it is locked (it should no longer slide).

3) Make sure horse’s mouth contains no feed before administration.

4) Remove syringe tip cover.

5) Insert syringe into the corner of the horse’s mouth.

6) Depress the plunger until it stops at the dose ring.


• The entire dose should be deposited on the back of the tongue or deep in the cheek pouch.

• Horses should be observed briefly to assure no part of the dose is lost or rejected.

• If any of the dose is lost, re-dosing is recommended.

• Replace cap if any unused doses remain in the syringe.


ACTIVE INGREDIENT: omeprazole 2.28 g.

USES: For the prevention of gastric ulcers in horses.

DOSAGE: The minimum recommended dosage is 1 mg/kg per day (0.45 mg/lb) or 1/4 syringe. When given once daily during the stressful period, ULCERGARD has been shown to effectively prevent stomach ulcers in horses. This effect was tested in horses exposed to stressful conditions for either 8 or 28 days.

WARNING: Not for use in humans. Keep this and all medications out of the reach of children. In case of ingestion by humans, contact a physician. Do not use in horses intended for human consumption. To obtain product information call 1-888-637-4251.

INFORMATION FOR HORSE OWNERS:

• ULCERGARD is intended for use in healthy horses. If you notice any signs of illness prior to or during the use of this product, consult your veterinarian for appropriate diagnosis and treatment recommendations.

• ULCERGARD may be used in horses that weigh at least 600 lbs. The effectiveness of ULCERGARD in the prevention of gastric ulcers in foals and weanlings has not been evaluated.

• ULCERGARD may be used safely in breeding stallions. Safety in pregnant mares has not been determined.

• One daily administration of ULCERGARD is recommended in horses exposed to stressful conditions which may include: training, racing, showing, traveling, stall confinement, and competition.

• ULCERGARD is intended for use only in the prevention of gastric ulcers in healthy horses. Clinical signs of gastric ulcers may include: decreased appetite, recurrent colic, intermittent loose stools or diarrhea, poor hair coat, poor body condition or poor performance. These signs may also be associated with other diseases as well as existing gastric ulcers. If your horse is exhibiting one or more of these signs, consult your veterinarian for diagnosis and treatment.

STORAGE INFORMATION: Store at 68°F-77°F (20-25°C). Excursions between 59°F-86°F (15-30°C) are permitted.

CUSTOMER ASSISTANCE AND WEB SITE: For more information, please call 1-888-637-4251 or visit our web site:

www.ULCERGARD.com.

®ULCERGARD is a registered trademark and Horse Head logo is a trademark of Boehringer Ingelheim Animal Health USA Inc. All rights reserved.

©2019 Boehringer Ingelheim Animal Health USA Inc.

Rev. 05-2019

Marketed by:

Boehringer Ingelheim Animal Health USA Inc., Duluth, GA 30096

Made in Brazil

US-EQU-0076-2021



Product Code

Net Wt. 6.15 g (2.28 g of omeprazole)
Contains 1 Syringe (4 Doses)



20 syringes per display pack

126649

40 syringe per refill pack

126652

10 X 6 syringes per show pack

126653

CPN: 1028331.0

COLORADO SERUM COMPANY4950 YORK STREET, P.O. BOX 16428, DENVER, CO, 80216-0428Telephone: 303-295-7527Order Desk: 800-525-2065Fax: 303-295-1923Website: www.colorado-serum.comEmail: colorado-serum@colorado-serum.comTHIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.

TETANUS TOXOID-CONCENTRATED

Colorado Serum

Adjuvanted

GENERAL INFORMATION: This product has been shown to be effective for the vaccination of healthy horses, cattle, sheep, goats, and swine against tetanus. This product was licensed prior to the requirement to establish a minimum age for use. The duration of immunity is unknown. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.

Safety in pregnant animals is unknown.

Tetanus Toxoid is prepared by detoxifying tetanus toxin in such a manner as to allow the antigenic properties to remain intact. Product is purified, concentrated and adjuvanted to provide a low dose effective immunizing agent.

Each serial is tested for purity, safety, and potency in accordance with USDA requirements.

Tetanus is caused by a neurotoxin produced by growth of Clostridium tetani, an anaerobic (lives without air) micro-organism, in necrotic tissue. Affected animals become stiff, have difficulty swallowing, and have an increased pulse rate. Breathing is labored. Spasmodic contractions of the muscular system occur, such as contracting muscles of the jaw.

Spasmodic contractions of the muscular system occur, such as contracting muscles of the jaw. Thus, the term “lockjaw” is often used. Legs and tail are often stiff with abdominal muscles contracted. Tetanus stricken animals may be unusually sensitive to light and heat. Temperature of the animal generally remains normal, elevating only shortly before death.

Protective antibody levels usually occur about two weeks after the second injection of the primary immunization series. In contrast, administration of Tetanus Antitoxin is recommended for immediate, emergency, passive treatment of exposed animals with unknown vaccination history or with signs of tetanus infection.

DIRECTIONS: Do not vaccinate within 21 days before slaughter. Store at 2-8° C. Do not freeze. Do not mix with other products. Shake well before use. Use entire contents when first opened.

PRECAUTIONS: A transitory local reaction may occur at injection site. Anaphylactoid reaction may occur following administration of products of this nature. If noted, administer adrenalin or equivalent. In case of human exposure, consult a physician.

DOSAGE & ADMINISTRATION: For primary immunization, two doses should be administered subcutaneously or intramuscularly approximately 30 days apart. Use intramuscularly for horses as local reactions are more likely to occur if injected subcutaneously.

Horses: 1 ml IM

Cattle: 1 ml SC or IM

Sheep, Goats, Swine: 0.5 ml SC or IM

Historically, annual single dose revaccination has been recommended. Contact veterinarian for advice.

OTHER INFORMATION: Contains thimerosal and formalin as preservatives. Tetanus Toxoid Concentrate is available in single dose size packaged 10 vials to the carton, and in 10 dose vials.

THE PEAK OF QUALITY SINCE 1923

VLN: 188 / PCN: 8601.00

COLORADO SERUM COMPANY, 4950 York Street, Denver, Colorado 80216

303-295-752

www.colorado-serum.com

Contact us for information on other Colorado Serum Company products. Fine Veterinary Products since 1923.

FOR VETERINARY USE ONLY

 

 

Order #

10 - 1 ml vials

10 - 1 dose vials

11411

10 ml

10 doses

11415

CPN: 1101033.3

Products

Dimensions

Care information

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
View full details

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)